# US 2013/0018172 A1 · Metal Abstraction Peptide and Uses Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0018172 A1
- Document ID: US20130018172A1
- Status: Published application
- Kind: A1
- Application number: 13/350,247
- Filed: 2012-01-13
- Published: 2013-01-17
- Earliest claimed: 2011-01-13
- Assignees: Echogen, Inc.; University of Kansas
- Inventors: Jennifer Ann Stowell Laurence; Mary Elizabeth Krause; Timothy A. Jackson; George Laurence
- Web page: https://patentgrep.com/patent/US20130018172A1

## CPC

- A61K 38/06: Tripeptides
- C07K 5/0806: {the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala}
- C07K 5/0819: {with the first amino acid being acidic}
- C07K 2319/20: containing a tag with affinity for a non-protein ligand
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Compositions comprising certain tripeptides which are capable of binding a metal in a square planar orientation, a square pyramidal orientation, or both, are disclosed in processes for modulating tagged peptides or proteins. Such compositions and processes may be used for site-specific chiral inversion of amino acids, site-specific peptide cleavage, and protein purification, among other uses.

## Claims

### Claim 1

A method of performing a site-specific chiral inversion of a tripeptide comprising complexing a metal ion with a tripeptide having a sequence LXLC1LC2 to form a metal ion-DXLC1DC2 complex,
wherein X is any amino acid such that the tripeptide and metal ion form a complex having a square planar orientation or square pyramidal orientation or both, and wherein C1 and C2 are the same or different; and wherein C1 is chosen from a cysteine and a cysteine-like nonnatural amino acid; and wherein C2 is chosen from a cysteine, a cysteine-like nonnatural amino acid, a histidine, and a histidine-like nonnatural amino acid.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The method of claim 1, wherein the metal ion is selected from the group consisting of nickel and palladium.

### Claim 4 (depends on 3)

The method of claim 3, wherein the metal ion is nickel.

### Claim 5 (depends on 1)

The method according to claim 1, wherein LX and DX are glycine.

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9 (depends on 1)

A method of providing anti-oxidant properties to a composition comprising
(i) providing a plurality of amino acids having a sequence LXLC1LC2 and a metal ion in a composition; and
(ii) performing the method of claim 1.

### Claim 10

An anti-oxidant composition comprising a metal ion complexed with a tripeptide having the sequence LXLC1LC2 to form a metal ion-DXLC1DC2 complex;
wherein X is any amino acid such that the tripeptide and metal ion form a complex having a square planar orientation or square pyramidal orientation or both, and wherein C1 and C2 are the same or different; and wherein C1 is chosen from a cysteine and a cysteine-like nonnatural amino acid; and wherein C2 is chosen from a cysteine, a cysteine-like nonnatural amino acid, a histidine, and a histidine-like nonnatural amino acid.

### Claim 11

A method of performing a site-specific cleavage of a peptide comprising:
providing a peptide with a sequence XC1C2, wherein X is any amino acid such that the peptide and metal ion form a complex having a square planar orientation or square pyramidal orientation or both, and wherein CI and C2 are the same or different; and wherein C1 is chosen from a cysteine and a cysteine-like nonnatural amino acid; and wherein C2 is chosen from a cysteine, a cysteine-like nonnatural amino acid, a histidine, and a histidine-like nonnatural amino acid; and
combining a partial chelator with a metal capable of reacting with the sequence XC1C2; and
allowing cleavage of the peptide within or at a terminal portion of the sequence XC1C2.

### Claim 12 (depends on 11)

The method of claim 11, wherein the metal is copper or iron.

### Claim 13 (depends on 11)

The method of claim 11, further comprising an electron transfer component.

### Claim 14 (depends on 13)

The method of claim 13, wherein said electron transfer component is selected from O2 or a species donating an electron.

### Claim 15 (depends on 11)

The method of claim 11, wherein the peptide further comprises at least one selected from the group consisting of: an affinity tag, a peptide, and a protein.

### Claim 16 (depends on 11)

The method of claim 11, wherein the peptide further comprises an affinity tag, the method further comprising immobilizing the peptide on a substrate for the affinity tag; and releasing a portion of the peptide from the substrate.

### Claim 17 (depends on 16)

The method of claim 16, further comprising recovering a portion of the peptide.

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20

A kit comprising a peptide having a sequence comprising XC1C2, wherein X is any amino acid, C1 and C2 are the same or different, C1 is chosen from a cysteine and a cysteine-like nonnatural amino acid, and C2 is chosen from a cysteine, a cysteine-like nonnatural amino acid, a histidine, and a histidine-like nonnatural amino acid; and a partial chelator with a metal capable of reacting with the sequence XC1C2.

### Claim 21

A method of protein purification comprising;
a) binding a first composition comprising a target protein associated with a linker and an affinity tag to an affinity material comprising a ligand capable of capturing the first composition;
b) providing a metal-containing cleavage agent capable of detaching the target protein from the first composition such that the detached target protein is devoid of any supplementary amino acids originating from the linker or the affinity tag; and
c) separating the target protein from the first composition.

### Claim 22 (depends on 21)

The method of claim 21, wherein the cleavage agent comprises a metal ion.

### Claim 23 (depends on 22)

The method of claim 22, wherein the cleavage agent comprises copper.

### Claim 24 (depends on 22)

The method of claim 22, wherein the cleavage agent comprises Cu(II).

### Claim 25 (depends on 22)

The method of claim 22, wherein the cleavage agent partially chelates the metal ion.

### Claim 26 (depends on 21)

The method of claim 21, wherein the linker comprises a peptide sequence comprising a tripeptide with the sequence XC1C2, wherein X is any amino acid and wherein C1 is chosen from a cysteine and a cysteine-like nonnatural amino acid, and C2 is chosen from a cysteine, a cysteine-like nonnatural amino acid, a histidine, and a histidine-like nonnatural amino acid.

### Claim 27 (depends on 21)

The method of claim 21, wherein the affinity tag comprises a tag from the group consisting of maltose binding protein, gluotathione-S-transferase, poly(His), biotin ligase tags, Strep, HaloTag, cellulose binding domain, gluotathione transferase, and glycan.

### Claim 28 (depends on 21)

The method of claim 21, wherein the ligand is associated with a substrate.

### Claim 29 (depends on 21)

The method of claim 21, wherein the affinity tag in said first composition binds the ligand in said affinity material irreversibly.

### Claim 30 (depends on 21)

The method of claim 21, wherein the linker in said first composition binds to and removes the metal ion from said cleavage agent.

### Claim 31 (depends on 21)

The method of claim 21, wherein the method further comprises preparing the target protein for therapeutic administration.

### Claim 32 (depends on 21)

The method of claim 21, wherein the affinity material is discarded after a single use.

### Claim 33

A composition for purifying a protein comprising;
a) an affinity tag, wherein the affinity tag is capable of binding to a ligand; and
b) a linker associated with the affinity tag, wherein the linker is covalently attached to a target protein;
wherein the entirety of the affinity tag and the linker are capable of being detached from the target protein by the addition of a cleavage agent comprising a metal ion.

### Claim 34

(canceled)

### Claim 35

(canceled)

### Claim 36 (depends on 33)

The composition of claim 33, wherein the linker comprises a peptide sequence comprising a tripeptide with the sequence XC1C2, wherein X is any amino acid and wherein C1 is chosen from a cysteine and a cysteine-like nonnatural amino acid, and C2 is chosen from a cysteine, a cysteine-like nonnatural amino acid, a histidine, and a histidine-like nonnatural amino acid.

### Claim 37 (depends on 33)

The composition of claim 33, wherein the cleavage agent comprises copper.

### Claim 38 (depends on 37)

The composition of claim 37, wherein the cleavage agent comprises Cu(II).

### Claim 39 (depends on 33)

The composition of claim 33, wherein the metal ion is partially chelated in the cleavage agent.

### Claim 40 (depends on 33)

The composition of claim 33, wherein the affinity tag comprises a tag from the group consisting of maltose binding protein, gluotathione-S-transferase, poly(His), biotin ligase tags, Strep, HaloTag, cellulose binding domain, gluotathione transferase, and glycan.

### Claim 41 (depends on 33)

The composition of claim 33, wherein the ligand is associated with a substrate.

### Claim 42 (depends on 33)

The composition of claim 33, wherein the affinity tag is capable of binding the ligand irreversibly.

### Claim 43 (depends on 33)

The composition of claim 33, wherein the linker is capable of capturing the metal ion in said cleavage agent irreversibly.

### Claim 44 (depends on 21)

A protein purified according to the method of claim 21.

### Claim 45 (depends on 44)

A composition comprising a protein according to claim 44 and further comprising said protein coupled with (i) an affinity tag, (ii) a linker, or (iii) an affinity tag and a linker.

### Claim 46 (depends on 45)

The composition of claim 45, wherein said linker comprises a peptide sequence comprising a tripeptide with the sequence XC1C2, wherein X is any amino acid and wherein C1 is chosen from a cysteine and a cysteine-like nonnatural amino acid, and C2 is chosen from a cysteine, a cysteine-like nonnatural amino acid, a histidine, and a histidine-like nonnatural amino acid.

### Claim 47 (depends on 44)

A composition comprising a protein according to claim 44 and further comprising a cleavage agent wherein said cleavage agent comprises a partial chelator and a metal.

### Claim 48 (depends on 47)

The composition of claim 47, wherein said metal is copper.
